A citation-based method for searching scientific literature

G Bulfield, W G Siller, P A Wight, K J Moore. Proc Natl Acad Sci U S A 1984
Times Cited: 1365







List of co-cited articles
1137 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



The molecular basis of muscular dystrophy in the mdx mouse: a point mutation.
P Sicinski, Y Geng, A S Ryder-Cook, E A Barnard, M G Darlison, P J Barnard. Science 1989
985
22

Animal models of Duchenne muscular dystrophy: from basic mechanisms to gene therapy.
Joe W McGreevy, Chady H Hakim, Mark A McIntosh, Dongsheng Duan. Dis Model Mech 2015
232
20

Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy.
A E Deconinck, J A Rafael, J A Skinner, S C Brown, A C Potter, L Metzinger, D J Watt, J G Dickson, J M Tinsley, K E Davies. Cell 1997
556
16


Humanizing the mdx mouse model of DMD: the long and the short of it.
Nora Yucel, Alex C Chang, John W Day, Nadia Rosenthal, Helen M Blau. NPJ Regen Med 2018
44
31

Dystrophin-deficient mdx mice display a reduced life span and are susceptible to spontaneous rhabdomyosarcoma.
Jeffrey S Chamberlain, Joseph Metzger, Morayma Reyes, DeWayne Townsend, John A Faulkner. FASEB J 2007
226
12

Pharmacological advances for treatment in Duchenne muscular dystrophy.
Simon Guiraud, Kay E Davies. Curr Opin Pharmacol 2017
80
15

The TREAT-NMD DMD Global Database: analysis of more than 7,000 Duchenne muscular dystrophy mutations.
Catherine L Bladen, David Salgado, Soledad Monges, Maria E Foncuberta, Kyriaki Kekou, Konstantina Kosma, Hugh Dawkins, Leanne Lamont, Anna J Roy, Teodora Chamova,[...]. Hum Mutat 2015
293
12

The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy.
H H Stedman, H L Sweeney, J B Shrager, H C Maguire, R A Panettieri, B Petrof, M Narusawa, J M Leferovich, J T Sladky, A M Kelly. Nature 1991
726
12

Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management.
Katharine Bushby, Richard Finkel, David J Birnkrant, Laura E Case, Paula R Clemens, Linda Cripe, Ajay Kaul, Kathi Kinnett, Craig McDonald, Shree Pandya,[...]. Lancet Neurol 2010
11

The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy.
G Nigro, L I Comi, L Politano, R J Bain. Int J Cardiol 1990
398
10

Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy.
Chengzu Long, Leonela Amoasii, Alex A Mireault, John R McAnally, Hui Li, Efrain Sanchez-Ortiz, Samadrita Bhattacharyya, John M Shelton, Rhonda Bassel-Duby, Eric N Olson. Science 2016
557
10

Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy.
R M Grady, H Teng, M C Nichol, J C Cunningham, R S Wilkinson, J R Sanes. Cell 1997
499
10


Generation of muscular dystrophy model rats with a CRISPR/Cas system.
Katsuyuki Nakamura, Wataru Fujii, Masaya Tsuboi, Jun Tanihata, Naomi Teramoto, Shiho Takeuchi, Kunihiko Naito, Keitaro Yamanouchi, Masugi Nishihara. Sci Rep 2014
85
10

Characterization of dystrophin deficient rats: a new model for Duchenne muscular dystrophy.
Thibaut Larcher, Aude Lafoux, Laurent Tesson, Séverine Remy, Virginie Thepenier, Virginie François, Caroline Le Guiner, Helicia Goubin, Maéva Dutilleul, Lydie Guigand,[...]. PLoS One 2014
93
9


Effect of genetic background on the dystrophic phenotype in mdx mice.
William D Coley, Laurent Bogdanik, Maria Candida Vila, Qing Yu, Jack H Van Der Meulen, Sree Rayavarapu, James S Novak, Marie Nearing, James L Quinn, Allison Saunders,[...]. Hum Mol Genet 2016
96
9

Muscle damage in mdx (dystrophic) mice: role of calcium and reactive oxygen species.
Nicholas P Whitehead, Ella W Yeung, David G Allen. Clin Exp Pharmacol Physiol 2006
198
9

Gene editing restores dystrophin expression in a canine model of Duchenne muscular dystrophy.
Leonela Amoasii, John C W Hildyard, Hui Li, Efrain Sanchez-Ortiz, Alex Mireault, Daniel Caballero, Rachel Harron, Thaleia-Rengina Stathopoulou, Claire Massey, John M Shelton,[...]. Science 2018
224
9

Dystrophin expression in muscle stem cells regulates their polarity and asymmetric division.
Nicolas A Dumont, Yu Xin Wang, Julia von Maltzahn, Alessandra Pasut, C Florian Bentzinger, Caroline E Brun, Michael A Rudnicki. Nat Med 2015
253
9

The Pathogenesis and Therapy of Muscular Dystrophies.
Simon Guiraud, Annemieke Aartsma-Rus, Natassia M Vieira, Kay E Davies, Gert-Jan B van Ommen, Louis M Kunkel. Annu Rev Genomics Hum Genet 2015
170
9

Force and power output of fast and slow skeletal muscles from mdx mice 6-28 months old.
G S Lynch, R T Hinkle, J S Chamberlain, S V Brooks, J A Faulkner. J Physiol 2001
233
9

Muscular dystrophy in the mdx mouse is a severe myopathy compounded by hypotrophy, hypertrophy and hyperplasia.
William Duddy, Stephanie Duguez, Helen Johnston, Tatiana V Cohen, Aditi Phadke, Heather Gordish-Dressman, Kanneboyina Nagaraju, Viola Gnocchi, SiewHui Low, Terence Partridge. Skelet Muscle 2015
66
13

Short telomeres and stem cell exhaustion model Duchenne muscular dystrophy in mdx/mTR mice.
Alessandra Sacco, Foteini Mourkioti, Rose Tran, Jinkuk Choi, Michael Llewellyn, Peggy Kraft, Marina Shkreli, Scott Delp, Jason H Pomerantz, Steven E Artandi,[...]. Cell 2010
301
9

Pax7 is required for the specification of myogenic satellite cells.
P Seale, L A Sabourin, A Girgis-Gabardo, A Mansouri, P Gruss, M A Rudnicki. Cell 2000
9

Dystrophin protects the sarcolemma from stresses developed during muscle contraction.
B J Petrof, J B Shrager, H H Stedman, A M Kelly, H L Sweeney. Proc Natl Acad Sci U S A 1993
9

Mammalian animal models for Duchenne muscular dystrophy.
Raffaella Willmann, Stefanie Possekel, Judith Dubach-Powell, Thomas Meier, Markus A Ruegg. Neuromuscul Disord 2009
136
8

Role of telomere dysfunction in cardiac failure in Duchenne muscular dystrophy.
Foteini Mourkioti, Jackie Kustan, Peggy Kraft, John W Day, Ming-Ming Zhao, Maria Kost-Alimova, Alexei Protopopov, Ronald A DePinho, Daniel Bernstein, Alan K Meeker,[...]. Nat Cell Biol 2013
89
8

Genetic background affects properties of satellite cells and mdx phenotypes.
So-ichiro Fukada, Daisuke Morikawa, Yukiko Yamamoto, Tokuyuki Yoshida, Noriaki Sumie, Masahiko Yamaguchi, Takahito Ito, Yuko Miyagoe-Suzuki, Shin'ichi Takeda, Kazutake Tsujikawa,[...]. Am J Pathol 2010
99
8



Daily treatment with SMTC1100, a novel small molecule utrophin upregulator, dramatically reduces the dystrophic symptoms in the mdx mouse.
Jonathon M Tinsley, Rebecca J Fairclough, Richard Storer, Fraser J Wilkes, Allyson C Potter, Sarah E Squire, Dave S Powell, Anna Cozzoli, Roberta F Capogrosso, Adam Lambert,[...]. PLoS One 2011
120
8

Expression of full-length utrophin prevents muscular dystrophy in mdx mice.
J Tinsley, N Deconinck, R Fisher, D Kahn, S Phelps, J M Gillis, K Davies. Nat Med 1998
438
8

The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion.
M Koenig, A H Beggs, M Moyer, S Scherpf, K Heindrich, T Bettecken, G Meng, C R Müller, M Lindlöf, H Kaariainen,[...]. Am J Hum Genet 1989
802
8

CRISPR-Cas9 corrects Duchenne muscular dystrophy exon 44 deletion mutations in mice and human cells.
Yi-Li Min, Hui Li, Cristina Rodriguez-Caycedo, Alex A Mireault, Jian Huang, John M Shelton, John R McAnally, Leonela Amoasii, Pradeep P A Mammen, Rhonda Bassel-Duby,[...]. Sci Adv 2019
93
8

The Dystrophin Complex: Structure, Function, and Implications for Therapy.
Quan Q Gao, Elizabeth M McNally. Compr Physiol 2015
123
8

Mechanisms of muscle degeneration, regeneration, and repair in the muscular dystrophies.
Gregory Q Wallace, Elizabeth M McNally. Annu Rev Physiol 2009
206
8

Towards developing standard operating procedures for pre-clinical testing in the mdx mouse model of Duchenne muscular dystrophy.
Miranda D Grounds, Hannah G Radley, Gordon S Lynch, Kanneboyina Nagaraju, Annamaria De Luca. Neurobiol Dis 2008
230
8

The mdx mouse skeletal muscle myopathy: I. A histological, morphometric and biochemical investigation.
G R Coulton, J E Morgan, T A Partridge, J C Sloper. Neuropathol Appl Neurobiol 1988
300
8

In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy.
Christopher E Nelson, Chady H Hakim, David G Ousterout, Pratiksha I Thakore, Eirik A Moreb, Ruth M Castellanos Rivera, Sarina Madhavan, Xiufang Pan, F Ann Ran, Winston X Yan,[...]. Science 2016
648
8

Prevention of muscular dystrophy in mice by CRISPR/Cas9-mediated editing of germline DNA.
Chengzu Long, John R McAnally, John M Shelton, Alex A Mireault, Rhonda Bassel-Duby, Eric N Olson. Science 2014
395
8

Phenotype of dystrophinopathy in old mdx mice.
J P Lefaucheur, C Pastoret, A Sebille. Anat Rec 1995
158
8


Dystrophin-deficient pigs provide new insights into the hierarchy of physiological derangements of dystrophic muscle.
Nikolai Klymiuk, Andreas Blutke, Alexander Graf, Sabine Krause, Katinka Burkhardt, Annegret Wuensch, Stefan Krebs, Barbara Kessler, Valeri Zakhartchenko, Mayuko Kurome,[...]. Hum Mol Genet 2013
85
8

Progress toward Gene Therapy for Duchenne Muscular Dystrophy.
Joel R Chamberlain, Jeffrey S Chamberlain. Mol Ther 2017
100
7

The muscular dystrophies.
Alan E H Emery. Lancet 2002
932
7

Differential expression of dystrophin isoforms in strains of mdx mice with different mutations.
W B Im, S F Phelps, E H Copen, E G Adams, J L Slightom, J S Chamberlain. Hum Mol Genet 1996
157
7

Single-cut genome editing restores dystrophin expression in a new mouse model of muscular dystrophy.
Leonela Amoasii, Chengzu Long, Hui Li, Alex A Mireault, John M Shelton, Efrain Sanchez-Ortiz, John R McAnally, Samadrita Bhattacharyya, Florian Schmidt, Dirk Grimm,[...]. Sci Transl Med 2017
108
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.